(Q36602771)

15 August 2017

1 reference

title

Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects (English)

1 reference

15 August 2017

1 reference

Marinos C Dalakas

1

1 reference

15 August 2017

publication date

1 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

253 Suppl 5

1 reference

15 August 2017

page(s)

V25-32

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-006-5004-0

15 August 2017

exact match

0 references

cites work

The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

Inflammatory, immune, and viral aspects of inclusion-body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

Markedly elevated GAD antibodies in SPS: effects of age and illness duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-5004-0

IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment

21 January 2018

1 reference

12 December 2020

Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.

1 reference

12 December 2020

The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies

1 reference

12 December 2020

The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile

1 reference

12 December 2020

Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity.

1 reference

12 December 2020

Polymyositis and dermatomyositis

1 reference

12 December 2020

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease

1 reference

12 December 2020

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

1 reference

12 December 2020

The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice

1 reference

12 December 2020

Treatment of stiff-man syndrome with intravenous immunoglobulin

1 reference

12 December 2020

Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production

1 reference

12 December 2020

Brain gamma-aminobutyric acid changes in stiff-person syndrome

1 reference

12 December 2020

Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset

1 reference

12 December 2020

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

1 reference

12 December 2020

Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome

1 reference

12 December 2020

Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies.

1 reference

12 December 2020

Anxiety at the frontier of molecular medicine

1 reference

12 December 2020

Stiff man syndrome: neurophysiological findings in eight patients

1 reference

12 December 2020

Autoantibody profiles and neurological correlations of thymoma

1 reference

12 December 2020

Inhibiting leukocyte recruitment to the brain by IVIg: is it relevant to the treatment of demyelinating CNS disorders?

1 reference

12 December 2020

Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial.

1 reference

12 December 2020

High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome

1 reference

12 December 2020

Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition

1 reference

12 December 2020

Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations.

1 reference

12 December 2020

Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin

1 reference

12 December 2020

Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy

1 reference

12 December 2020

Stiff-person Syndrome.

1 reference

12 December 2020

Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies

1 reference

12 December 2020

Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1.

1 reference

12 December 2020

Inflammation and Alzheimer's disease

1 reference

12 December 2020

Immune responses to Campylobacter and serum autoantibodies in patients with complex regional pain syndrome

1 reference

12 December 2020

Human pooled immunoglobulin in the treatment of chronic pain syndromes

1 reference

12 December 2020

Successful treatment of stiff man syndrome with intravenous immunoglobulin

1 reference

12 December 2020

Pathogenetic mechanisms of post-polio syndrome: morphological, electrophysiological, virological, and immunological correlations

1 reference

12 December 2020

Pro-inflammatory cytokines and motor neuron dysfunction: is there a connection in post-polio syndrome?

1 reference

12 December 2020

Intravenous immunoglobulin in autoimmune neuromuscular diseases

1 reference

12 December 2020

Molecular immunology and genetics of inflammatory muscle diseases

1 reference

12 December 2020

Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers

1 reference

12 December 2020

Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome

1 reference

12 December 2020

Prior poliomyelitis-evidence of cytokine production in the central nervous system

1 reference

12 December 2020

The clinical significance of an autoimmune response against glutamic acid decarboxylase

1 reference

12 December 2020

Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.

1 reference

12 December 2020

10.1007/S00415-006-5004-0

Identifiers

DOI

1 reference

15 August 2017

1 reference